FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2795019304> ?p ?o ?g. }

• W2795019304 endingPage "1456" @default.
• W2795019304 startingPage "1447" @default.
• W2795019304 abstract "B cell maturation antigen (BCMA) has recently been identified as an important multiple myeloma (MM)-specific target for chimeric antigen receptor (CAR) T cell therapy. In CAR T cell therapy targeting CD19 for lymphoma, host immune anti-murine CAR responses limited the efficacy of repeat dosing and possibly long-term persistence. This clinically relevant concern can be addressed by generating a CAR incorporating a human single-chain variable fragment (scFv). We screened a human B cell-derived scFv phage display library and identified a panel of BCMA-specific clones from which human CARs were engineered. Despite a narrow range of affinity for BCMA, dramatic differences in CAR T cell expansion were observed between unique scFvs in a repeat antigen stimulation assay. These results were confirmed by screening in a MM xenograft model, where only the top preforming CARs from the repeat antigen stimulation assay eradicated disease and prolonged survival. The results of this screening identified a highly effective CAR T cell therapy with properties, including rapid in vivo expansion (>10,000-fold, day 6), eradication of large tumor burden, and durable protection to tumor re-challenge. We generated a bicistronic construct including a second-generation CAR and a truncated-epithelial growth factor receptor marker. CAR T cell vectors stemming from this work are under clinical investigation. B cell maturation antigen (BCMA) has recently been identified as an important multiple myeloma (MM)-specific target for chimeric antigen receptor (CAR) T cell therapy. In CAR T cell therapy targeting CD19 for lymphoma, host immune anti-murine CAR responses limited the efficacy of repeat dosing and possibly long-term persistence. This clinically relevant concern can be addressed by generating a CAR incorporating a human single-chain variable fragment (scFv). We screened a human B cell-derived scFv phage display library and identified a panel of BCMA-specific clones from which human CARs were engineered. Despite a narrow range of affinity for BCMA, dramatic differences in CAR T cell expansion were observed between unique scFvs in a repeat antigen stimulation assay. These results were confirmed by screening in a MM xenograft model, where only the top preforming CARs from the repeat antigen stimulation assay eradicated disease and prolonged survival. The results of this screening identified a highly effective CAR T cell therapy with properties, including rapid in vivo expansion (>10,000-fold, day 6), eradication of large tumor burden, and durable protection to tumor re-challenge. We generated a bicistronic construct including a second-generation CAR and a truncated-epithelial growth factor receptor marker. CAR T cell vectors stemming from this work are under clinical investigation." @default.
• W2795019304 created "2018-04-06" @default.
• W2795019304 creator A5005178144 @default.
• W2795019304 creator A5005388459 @default.
• W2795019304 creator A5006013523 @default.
• W2795019304 creator A5011077747 @default.
• W2795019304 creator A5032542716 @default.
• W2795019304 creator A5036831073 @default.
• W2795019304 creator A5042026897 @default.
• W2795019304 creator A5042888186 @default.
• W2795019304 creator A5057287134 @default.
• W2795019304 creator A5064886770 @default.
• W2795019304 creator A5065556543 @default.
• W2795019304 creator A5069849487 @default.
• W2795019304 creator A5091383290 @default.
• W2795019304 creator A5091643041 @default.
• W2795019304 date "2018-06-01" @default.
• W2795019304 modified "2023-10-17" @default.
• W2795019304 title "Development and Evaluation of an Optimal Human Single-Chain Variable Fragment-Derived BCMA-Targeted CAR T Cell Vector" @default.
• W2795019304 cites W1661103064 @default.
• W2795019304 cites W1916979945 @default.
• W2795019304 cites W1964097992 @default.
• W2795019304 cites W1981150156 @default.
• W2795019304 cites W1982877913 @default.
• W2795019304 cites W1988382766 @default.
• W2795019304 cites W2035285625 @default.
• W2795019304 cites W2056662191 @default.
• W2795019304 cites W2066186103 @default.
• W2795019304 cites W2077650095 @default.
• W2795019304 cites W2082189475 @default.
• W2795019304 cites W2083262808 @default.
• W2795019304 cites W2110641339 @default.
• W2795019304 cites W2129702476 @default.
• W2795019304 cites W2153147430 @default.
• W2795019304 cites W2264350526 @default.
• W2795019304 cites W2342423058 @default.
• W2795019304 cites W2344653410 @default.
• W2795019304 cites W2471662063 @default.
• W2795019304 cites W2509364267 @default.
• W2795019304 cites W2530531760 @default.
• W2795019304 cites W2569050105 @default.
• W2795019304 cites W2594388103 @default.
• W2795019304 cites W2773804840 @default.
• W2795019304 cites W2775369717 @default.
• W2795019304 cites W2787301955 @default.
• W2795019304 cites W2787621143 @default.
• W2795019304 doi "https://doi.org/10.1016/j.ymthe.2018.03.016" @default.
• W2795019304 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5986730" @default.
• W2795019304 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29678657" @default.
• W2795019304 hasPublicationYear "2018" @default.
• W2795019304 type Work @default.
• W2795019304 sameAs 2795019304 @default.
• W2795019304 citedByCount "75" @default.
• W2795019304 countsByYear W27950193042018 @default.
• W2795019304 countsByYear W27950193042019 @default.
• W2795019304 countsByYear W27950193042020 @default.
• W2795019304 countsByYear W27950193042021 @default.
• W2795019304 countsByYear W27950193042022 @default.
• W2795019304 countsByYear W27950193042023 @default.
• W2795019304 crossrefType "journal-article" @default.
• W2795019304 hasAuthorship W2795019304A5005178144 @default.
• W2795019304 hasAuthorship W2795019304A5005388459 @default.
• W2795019304 hasAuthorship W2795019304A5006013523 @default.
• W2795019304 hasAuthorship W2795019304A5011077747 @default.
• W2795019304 hasAuthorship W2795019304A5032542716 @default.
• W2795019304 hasAuthorship W2795019304A5036831073 @default.
• W2795019304 hasAuthorship W2795019304A5042026897 @default.
• W2795019304 hasAuthorship W2795019304A5042888186 @default.
• W2795019304 hasAuthorship W2795019304A5057287134 @default.
• W2795019304 hasAuthorship W2795019304A5064886770 @default.
• W2795019304 hasAuthorship W2795019304A5065556543 @default.
• W2795019304 hasAuthorship W2795019304A5069849487 @default.
• W2795019304 hasAuthorship W2795019304A5091383290 @default.
• W2795019304 hasAuthorship W2795019304A5091643041 @default.
• W2795019304 hasBestOaLocation W27950193041 @default.
• W2795019304 hasConcept C147483822 @default.
• W2795019304 hasConcept C159654299 @default.
• W2795019304 hasConcept C203014093 @default.
• W2795019304 hasConcept C2777701055 @default.
• W2795019304 hasConcept C2778453870 @default.
• W2795019304 hasConcept C2778957590 @default.
• W2795019304 hasConcept C3875195 @default.
• W2795019304 hasConcept C502942594 @default.
• W2795019304 hasConcept C86803240 @default.
• W2795019304 hasConcept C8891405 @default.
• W2795019304 hasConceptScore W2795019304C147483822 @default.
• W2795019304 hasConceptScore W2795019304C159654299 @default.
• W2795019304 hasConceptScore W2795019304C203014093 @default.
• W2795019304 hasConceptScore W2795019304C2777701055 @default.
• W2795019304 hasConceptScore W2795019304C2778453870 @default.
• W2795019304 hasConceptScore W2795019304C2778957590 @default.
• W2795019304 hasConceptScore W2795019304C3875195 @default.
• W2795019304 hasConceptScore W2795019304C502942594 @default.
• W2795019304 hasConceptScore W2795019304C86803240 @default.
• W2795019304 hasConceptScore W2795019304C8891405 @default.
• W2795019304 hasFunder F4320306378 @default.
• W2795019304 hasFunder F4320306439 @default.
• W2795019304 hasFunder F4320306571 @default.

• next